| CTRI Number |
CTRI/2024/01/061584 [Registered on: 18/01/2024] Trial Registered Prospectively |
| Last Modified On: |
15/01/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Physiotherapy (Not Including YOGA) |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Additive Effect Of Aerobic Exercise With Motivational Interviewing On Toxin Removal , Functional Capacity & Quality Of Life In Chronic Kidney Disease Patients |
|
Scientific Title of Study
|
Additive Effect Of Aerobic Exercise With Motivational Interviewing On Toxin Removal Functional Capacity & Quality Of Life In Chronic Kidney Disease Patients |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Arshiya Ismail Sayyed |
| Designation |
Master Of Cardiovascular& Respiratory Physiotherapy Student |
| Affiliation |
Maharashtra Institute Of Physiotherapy |
| Address |
Maharashtra Institute of Physiotherapy MIMSR Medical Campus 15
Physiotherapy Cardiovascular Respiratory Department Ambajogai
road Latur
Latur
Latur MAHARASHTRA 413531 India |
| Phone |
8956568562 |
| Fax |
|
| Email |
arshiyasayyed8956@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Vishvanath Pawadshetty |
| Designation |
Professor & HOD of Cardiovascular & Respiratory Physiotherapy |
| Affiliation |
Maharashtra Institute Of Physiotherapy |
| Address |
Maharashtra Institute of Physiotherapy MIMSR Medical Campus 15
Physiotherapy CardiovascularRespiratory Department Ambajogai
road Latur
Latur
Latur MAHARASHTRA 413 531 India |
| Phone |
9422710990 |
| Fax |
|
| Email |
physiovish@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Vishvanath Pawadshetty |
| Designation |
Professor & HOD of Cardiovascular & Respiratory Physiotherapy |
| Affiliation |
Maharashtra Institute Of Physiotherapy |
| Address |
Maharashtra Institute of Physiotherapy MIMSR Medical Campus 15
Physiotherapy CardiovascularRespiratory Department Ambajogai
road Latur
Latur
Latur MAHARASHTRA 413 531 India |
| Phone |
9422710990 |
| Fax |
|
| Email |
physiovish@gmail.com |
|
|
Source of Monetary or Material Support
|
| Maharashtra Institute of Physiotherapy Latur |
|
|
Primary Sponsor
|
| Name |
Maharshtra institute of physiotherapy latur |
| Address |
Maharashtra Institute of Physiotherapy MIMSR Medical Campus Physiotherapy cardiovascular-respiratory department Ambajogai road latur Maharashtra 413512 India
|
| Type of Sponsor |
Other [] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Arshiya Sayyed |
Maharashtra Institute of Physiotherapy |
Maharashtra Institute of Physiotherapy MIMSR Medical Campus
Physiotherapy Cardiovascular Respiratory Department Ambajogai
road Latur
Latur MAHARASHTRA |
08956568562
arshiyasayyed8956@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Maharashtra Institute Of physiotherapy, Ethical Committee Latur |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: N189||Chronic kidney disease, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Group A Aerobic exercise with motivational interviewing
Group B Motivational interviewing |
Group A Aerobic exercise with motivational interviewing 2 times a week for 8 weeks
Group B Motivational interviewing 2 times a week for 8 weeks |
| Comparator Agent |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
Known case of chronic kidney disease( stage 3-5).
Patients willing to participate.
RPE (12-15 on Borg scale)
|
|
| ExclusionCriteria |
| Details |
Unstable vitals
Restless leg syndrome
Recent episode of cerebrovascular accidents
Acute coronary syndrome, CCF, Severe pneumonia in st one month.
Musculoskeletal abnormalities (rheumatoid arthritis & osteoarthritis of knee and hip, fracture hip).
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
Toxin level : Kidney function test
Functional capacity: 6 minute walk test.
Health related quality of life: Kidney disease quality of life questionnaire (KDQOL)
|
Pre intervention assessment and post intervention assessment after 8 weeks of Intervention
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| NIL |
NIL |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
26/01/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Chronic kidney disease patients will be randomly selected and divided randomly into two groups. One group will be given motivational interviewing (8 weeks protocol) and other group will be given Aerobic exercise with motivational interviewing (8 weeks protocol). Toxin level(Kidney function test), Functional capacity using 6 minute walk test & Kidney disease quality of life questionnaire will be taken before the treatment and after 8 weeks of treatment. |